1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biosimilars Market: By Product (Recombinant Non-Glycosylated Protein, Recombinant Glycosated Proteins, Peptides) By Technology (Monoclonal Antibodies Technology, Nuclear Magnetic Resonance Technology, Recombinant DNA Technology, Chromatography, Mass Spect

BioSimilar is a bio pharmaceutical drug that have similar property to the drug previously licensed. As the number of diseased people increase, the demand for cheaper drugs also increase leading to increase in biosimilars market.

The global market for the biosimilars is segmented into different product types by technology and application. Each of these segmentations has been further broken down into the sub segments to give an in-depth and comprehensive analysis of biosimilars market

Regulations for biosimilars play a vital role as they maintain a balance between original & biosimilar products. Currently the geographic biosimilar market is segmented into Americas, Europe, APAC and rest of the world.

Some of the key players included in the report are:
Novaritis (Sandoz)
Hospira
Glaxo Smith Kline
Pfizer
Teva
Biocon
Ranbaxy.

Table Of Contents

Biosimilars Market: By Product (Recombinant Non-Glycosylated Protein, Recombinant Glycosated Proteins, Peptides) By Technology (Monoclonal Antibodies Technology, Nuclear Magnetic Resonance Technology, Recombinant DNA Technology, Chromatography, Mass Spect
1. Global Biosimilars Market - Device Overview

2. Executive Summary

3. Global Biosimilars - Market Landscape

3.1. Market Share Analysis

3.2. Comparative Analysis

3.2.1. Product Benchmarking

3.2.2. End user profiling

3.2.3. Patent Analysis

3.2.4. Top 5 Financials Analysis

4. Global Biosimilars - Market Forces

4.1. Market Drivers

4.2. Market Constraints

4.3. Market Challenges

4.4. Attractiveness of the Biosimilars Industry

5. Global Biosimilars - Strategic Analysis

5.1. Value Chain Analysis

5.2. Pricing Analysis

5.3. Opportunities Analysis

5.4. Product/Market Life Cycle Analysis

5.5. Suppliers and Distributors

6. Biosimilars Market, By Technology

6.1. Monoclonal Antibodies Technology

6.2. Nuclear Magnetic Resonance Technology

6.3. Recombinant DNA Technology

6.4. Chromatography

6.5. Mass Spectroscopy

6.6. Electrophoresis

6.7. Western Blotting

6.8. Bioassay

7. Biosimilars Market, By Product Type

7.1. Recombinant Non-Glycosylated Protein

7.1.1 Human Growth Harmone

7.1.2 Insulin

7.1.3 Interferon

7.1.4 Granulocyte colony stimulating factor (G-CSF)

7.1.5 Others

7.2. Recombinant Glycosated Proteins

7.2.1 Erythropoietin

7.2.2 Monoclonal antibodies

7.2.3 Others

7.3. Peptides

8. Biosimilars Market, By Application

8.1. Blood disorders

8.2. Oncology Diseases

8.3. Chronic and autoimmune diseases

8.4. Growth hormone deficiency

8.5. Multimodal Nonlinear Optical (NLO) Imaging

9. Global Biosimilars-Regulatory Landscape Analysis

9.1. Regulations in United States

9.2. Regulations in Europe

9.3. Regulation in Asia

9.4. Comparison of Biosimilar medicine guidelines

10. Geographical Landscape - Biosimilars, By Region

10.1. Americas

10.2. Europe

10.3. Asia-Pacific

10.4. Rest of The World

11. Global Biosimilars- Market Entropy

11.1. New Product Launches

11.2. MandAs, Collaborations, JVs and Partnerships

12. Company Profiles

12.1. Novaritis(Sandoz)

12.2. Teva

12.3. Hospira

12.4. Biocon

12.5. Mylan

12.6. Ranbaxy

12.7. Watson

12.8. Actavis

12.9. Apotex

12.10. Stada

12.11. Other generics manufacturers

12.12. Pfizer

12.13. GlaxoSmithKline

12.14. Eli Lilly

12.15. Dr Reddy's

12.16. Wockhardt

12.17. Cipla

"*Financials would be provided on a best efforts basis for private companies"

13. Appendix

13.1. Abbreviations

13.2. Sources

13.3. Research Methodology

13.4. Expert Insights

13.5. The ARC Advantage

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

Global Biosimilar Drug Market Research Report 2016

Global Biosimilar Drug Market Research Report 2016

  • $ 2850
  • Industry report
  • November 2016
  • by 9Dimen Research

2016 Global Biosimilar Drug Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biosimilar Drug industry, focusing on the main regions ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.